BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McGrath T, Baskerville R, Rogero M, Castell L. Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases. Nutrients 2022;14:917. [PMID: 35267893 DOI: 10.3390/nu14050917] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh DD, Shati AA, Alfaifi MY, Elbehairi SEI, Han I, Choi E, Yadav DK. Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development. Cells 2022;11:3767. [DOI: 10.3390/cells11233767] [Reference Citation Analysis]
2 Wang S, Bian L, Yin Y, Guo J. Targeting NMDA Receptors in Emotional Disorders: Their Role in Neuroprotection. Brain Sci 2022;12:1329. [PMID: 36291261 DOI: 10.3390/brainsci12101329] [Reference Citation Analysis]
3 Gruenbaum BF, Zlotnik A, Fleidervish I, Frenkel A, Boyko M. Glutamate Neurotoxicity and Destruction of the Blood–Brain Barrier: Key Pathways for the Development of Neuropsychiatric Consequences of TBI and Their Potential Treatment Strategies. IJMS 2022;23:9628. [DOI: 10.3390/ijms23179628] [Reference Citation Analysis]
4 Roca-umbert A, Vogel-gonzález M, Fierro-villegas A, García-calleja J, Bosnjak A, Ill-raga G, Herrera-fernández V, Muntané G, Campelo F, Vicente R, Bosch E. Functional characterization of the Met50Val substitution in SLC30A9 as a novel case of adaptive introgression in humans.. [DOI: 10.1101/2022.06.29.498106] [Reference Citation Analysis]
5 Teleanu RI, Niculescu AG, Roza E, Vladâcenco O, Grumezescu AM, Teleanu DM. Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System. Int J Mol Sci 2022;23:5954. [PMID: 35682631 DOI: 10.3390/ijms23115954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]